36 related articles for article (PubMed ID: 15236318)
1. Hallmark discoveries in the biology of Wilms tumour.
Perotti D; Williams RD; Wegert J; Brzezinski J; Maschietto M; Ciceri S; Gisselsson D; Gadd S; Walz AL; Furtwaengler R; Drost J; Al-Saadi R; Evageliou N; Gooskens SL; Hong AL; Murphy AJ; Ortiz MV; O'Sullivan MJ; Mullen EA; van den Heuvel-Eibrink MM; Fernandez CV; Graf N; Grundy PE; Geller JI; Dome JS; Perlman EJ; Gessler M; Huff V; Pritchard-Jones K
Nat Rev Urol; 2024 Mar; 21(3):158-180. PubMed ID: 37848532
[TBL] [Abstract][Full Text] [Related]
2. CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma.
Wachowiak R; Mayer S; Suttkus A; Martynov I; Lacher M; Melling N; Izbicki JR; Tachezy M
Open Med (Wars); 2019; 14():920-927. PubMed ID: 31989042
[TBL] [Abstract][Full Text] [Related]
3. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.
Gratias EJ; Dome JS; Jennings LJ; Chi YY; Tian J; Anderson J; Grundy P; Mullen EA; Geller JI; Fernandez CV; Perlman EJ
J Clin Oncol; 2016 Sep; 34(26):3189-94. PubMed ID: 27400937
[TBL] [Abstract][Full Text] [Related]
4. Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.
Gratias EJ; Jennings LJ; Anderson JR; Dome JS; Grundy P; Perlman EJ
Cancer; 2013 Nov; 119(21):3887-94. PubMed ID: 23983061
[TBL] [Abstract][Full Text] [Related]
5. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.
Maschietto M; Trapé AP; Piccoli FS; Ricca TI; Dias AA; Coudry RA; Galante PA; Torres C; Fahhan L; Lourenço S; Grundy PE; de Camargo B; de Souza S; Neves EJ; Soares FA; Brentani H; Carraro DM
Cell Death Dis; 2011 Nov; 2(11):e224. PubMed ID: 22048167
[TBL] [Abstract][Full Text] [Related]
6. A protein complex network of Drosophila melanogaster.
Guruharsha KG; Rual JF; Zhai B; Mintseris J; Vaidya P; Vaidya N; Beekman C; Wong C; Rhee DY; Cenaj O; McKillip E; Shah S; Stapleton M; Wan KH; Yu C; Parsa B; Carlson JW; Chen X; Kapadia B; VijayRaghavan K; Gygi SP; Celniker SE; Obar RA; Artavanis-Tsakonas S
Cell; 2011 Oct; 147(3):690-703. PubMed ID: 22036573
[TBL] [Abstract][Full Text] [Related]
7. FGF/EGF signaling regulates the renewal of early nephron progenitors during embryonic development.
Brown AC; Adams D; de Caestecker M; Yang X; Friesel R; Oxburgh L
Development; 2011 Dec; 138(23):5099-112. PubMed ID: 22031548
[TBL] [Abstract][Full Text] [Related]
8. Candidate genes and potential targets for therapeutics in Wilms' tumour.
Blackmore C; Coppes MJ; Narendran A
Clin Transl Oncol; 2010 Sep; 12(9):597-605. PubMed ID: 20851800
[TBL] [Abstract][Full Text] [Related]
9. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.
Williams RD; Al-Saadi R; Chagtai T; Popov S; Messahel B; Sebire N; Gessler M; Wegert J; Graf N; Leuschner I; Hubank M; Jones C; Vujanic G; Pritchard-Jones K; ;
Clin Cancer Res; 2010 Apr; 16(7):2036-45. PubMed ID: 20332316
[TBL] [Abstract][Full Text] [Related]
10. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group.
Huang CC; Gadd S; Breslow N; Cutcliffe C; Sredni ST; Helenowski IB; Dome JS; Grundy PE; Green DM; Fritsch MK; Perlman EJ
Clin Cancer Res; 2009 Mar; 15(5):1770-8. PubMed ID: 19208794
[TBL] [Abstract][Full Text] [Related]
11. Late recurrence of Wilms' tumour with exclusive skeletal muscle phenotype 23 years after primary diagnosis.
Senetta R; Macrì L; Pacchioni D; Castellano I; Cassoni P; Bussolati G
Virchows Arch; 2007 Jan; 450(1):115-8. PubMed ID: 17111125
[TBL] [Abstract][Full Text] [Related]
12. The statistics of identifying differentially expressed genes in Expresso and TM4: a comparison.
Sioson AA; Mane SP; Li P; Sha W; Heath LS; Bohnert HJ; Grene R
BMC Bioinformatics; 2006 Apr; 7():215. PubMed ID: 16626497
[TBL] [Abstract][Full Text] [Related]
13. A gene expression signature for relapse of primary wilms tumors.
Li W; Kessler P; Yeger H; Alami J; Reeve AE; Heathcott R; Skeen J; Williams BR
Cancer Res; 2005 Apr; 65(7):2592-601. PubMed ID: 15805255
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior.
Lu YJ; Williamson D; Wang R; Summersgill B; Rodriguez S; Rogers S; Pritchard-Jones K; Campbell C; Shipley J
Genes Chromosomes Cancer; 2003 Nov; 38(3):207-14. PubMed ID: 14506694
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in the biology and management of Wilms tumor.
Wiener JS; Coppes MJ; Ritchey ML
J Urol; 1998 Apr; 159(4):1316-25. PubMed ID: 9507876
[TBL] [Abstract][Full Text] [Related]
17. Pediatric genitourinary tumors.
Buckley KS
Curr Opin Oncol; 2012 May; 24(3):291-6. PubMed ID: 22476187
[TBL] [Abstract][Full Text] [Related]
18. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines.
Williams RD; Hing SN; Greer BT; Whiteford CC; Wei JS; Natrajan R; Kelsey A; Rogers S; Campbell C; Pritchard-Jones K; Khan J
Genes Chromosomes Cancer; 2004 Sep; 41(1):65-79. PubMed ID: 15236318
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
